Answer
The mean elimination half-life of blinatumomab in adults receiving continuous intravenous infusion is 2.20 hours (SD 1.34 hours).
Sources for this answer
- BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusionAmgen Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 26Document updated
Sources checked